Bladder Adenocarcinoma: An Overview for the Newly Diagnosed

Adenocarcinoma of the bladder is a rare form of bladder cancer, accounting for less than 2% of all bladder cancers. Unlike the more common type, urothelial carcinoma (also called transitional cell carcinoma), adenocarcinoma originates from the glandular cells lining the bladder. These cells are similar to those found in the lining of the intestines.

This cancer often presents in one of two main ways:

• Primary Adenocarcinoma: This type originates directly within the bladder lining. It can sometimes arise from a condition called cystitis glandularis, where the bladder lining transforms into a glandular tissue.
• Secondary or Metastatic Adenocarcinoma: This is cancer that started elsewhere (most commonly the colon or prostate) and has spread to the bladder. Accurate diagnosis is crucial to distinguish primary bladder adenocarcinoma from secondary spread, as the treatment approaches are vastly different.

The most common symptom is hematuria (blood in the urine), often painless and visible to the patient. Other symptoms may include pain or burning during urination, urinary frequency, and urgency.

Diagnosis: Determining the Scope of the Disease

The diagnosis involves several steps to confirm the cancer type and stage.

1. Initial Procedures

• Cystoscopy and Biopsy: A flexible tube with a light and camera (cystoscope) is inserted through the urethra into the bladder. Any suspicious masses are visualized, and tissue samples (biopsies) are taken for analysis by a pathologist. This is the definitive step for diagnosis.
• Transurethral Resection of Bladder Tumor (TURBT): This procedure is often performed at the time of initial diagnosis to remove all visible tumor tissue and determine how deeply the cancer has invaded the bladder wall.

2. Staging and Imaging

Once cancer is confirmed, imaging is used to determine the stage, which dictates treatment.

• CT Scan (Chest, Abdomen, and Pelvis): This imaging scan is used to look for evidence of cancer spread (metastasis) to the lymph nodes or distant organs, such as the lungs or liver.
• MRI (Magnetic Resonance Imaging): Sometimes used instead of or in addition to a CT scan to get a more detailed look at the local extent of the tumor.
• PET Scan: Less common, but may be used to identify subtle areas of cancer spread that are not clear on other scans.

3. Pathological Confirmation

The pathologist will examine the biopsy samples to confirm that the cancer is indeed adenocarcinoma and determine the grade (how aggressive the cells look) and depth of invasion. They may also perform special stains, like immunohistochemistry, to help rule out the possibility of the cancer having spread from the colon or another organ.

Treatment Options

The treatment for adenocarcinoma of the bladder is highly dependent on the stage and location of the tumor.

1. Non-Muscle Invasive Disease (Early Stage)

If the tumor has not invaded the deeper muscle layer of the bladder wall (Stage 1/2):

• Transurethral Resection (TURBT): The tumor is surgically scraped away through the urethra. This may be the only treatment needed if the tumor is small and low-grade.
• Intravesical Therapy: Medications are instilled directly into the bladder via a catheter.
• Chemotherapy (e.g., Mitomycin C): Used to kill residual cancer cells on the bladder lining.
• Immunotherapy (e.g., BCG): Less effective for adenocarcinoma than for urothelial carcinoma, but may be considered in some cases.

2. Muscle Invasive Disease (Later Stage)

If the cancer has invaded the muscle layer (Stage 3) or is high-grade:

• Radical Cystectomy: This is the most common and often curative treatment. It involves the surgical removal of the entire bladder, nearby lymph nodes and potentially other organs (prostate/seminal vesicles in men, uterus/ovaries in women).
• Urinary Diversion: After the bladder is removed, a new way for the body to store and pass urine must be created (e.g., ileal conduit, neobladder or continent cutaneous pouch). This is a major part of the surgical planning.
• Chemotherapy:
• Neoadjuvant Chemotherapy: Given before surgery (cystectomy) to shrink the tumor and kill micrometastases, potentially improving the chances of cure.
• Adjuvant Chemotherapy: Given after surgery if the pathology suggests a high risk of recurrence.

3. Metastatic Disease (Stage 4)

If the cancer has spread outside the pelvis to distant organs:

• Systemic Chemotherapy: Chemotherapy drugs are given intravenously to travel throughout the body and attack cancer cells wherever they reside. Regimens often include drugs similar to those used for colon cancer (e.g., 5-fluorouracil, platinum agents), as the cells are biologically similar.
• Palliative Care: Focuses on relieving symptoms and improving quality of life, alongside active cancer treatment.

Potential Side Effects and Complications

Every treatment carries risks. Discuss these potential side effects with your oncologist.

TURBT: Common side effects include blood in urine, bladder spasm or pain on urination, and potential complications are bladder perforation or bleeding requiring transfusion.

Intravesical therapy: Bladder irritation, urgency, frequency, flu-like symptoms; Chemical cystitis (inflammation), infection.

Radical cystectomy and diversion: Pain, fatigue, bowel changes, infection, blood clots; Urinary Diversion Specific: Stoma/bag issues (ileal conduit), difficulty emptying (neobladder), electrolyte imbalance. Sexual/Reproductive: Erectile dysfunction (men), vaginal shortening (women).

Systemic chemotherapy: Fatigue, nausea, vomiting, hair loss, risk of infection (low white blood cell count), numbness/tingling in hands and feet (neuropathy); kidney damage, severe infection (sepsis).

Conclusion: Driving the Conversation

A diagnosis of adenocarcinoma of the bladder requires careful and specialized care. Because it is rare, it is essential to be treated by a multidisciplinary team, including a urologic oncologist, medical oncologist and radiation oncologist who have experience with this specific cancer type.

Key questions to ask your oncologist:

• What is the precise stage of my cancer, and has it invaded the muscle layer?
• Is this primary bladder cancer, or could it have spread from another organ?
• What is the rationale for recommending a radical cystectomy versus other options?
• What type of urinary diversion is best for my lifestyle, and what are the short- and long-term consequences of that choice?
• What role will chemotherapy play in my overall treatment plan?

Your partnership with your medical team is the most crucial factor in navigating your journey successfully.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.